Alexander Krujatz has around 20 years experience in pharma and consulting. Currently he is Chief Commercial Officer of Centrient Pharmaceuticals, responsible for the company's portofolio of antibiotics API and FDF, statins and anti fungals. Having begun his career in management consulting, Alexander moved to diverse commercial and managerial assignments in key geographies of Novartis’ Sandoz division. He was the Managing Director of Alcon (Nordic region), the largest eye care device company in the world, where he focused on turnaround and commercial execution. He joined Centrient Pharmaceuticals in December of 2021.